ARS Pharmaceuticals, Inc.
SPRY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671858
No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding ARS Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 100 | 113 | +13 |
| Shares | 65.4M | 59.9M | −5.53M (−8.5%) |
| Value | $358.5M | $612.1M | +$253.6M (+70.7%) |
New holders (27)
Institutions that held ARS Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (14)
Institutions that held ARS Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Charles Schwab Trust Co | 3,996,071 | $21.9M |
| Baker Bros. Advisors LP | 2,006,451 | $11.0M |
| Nantahala Capital Management, LLC | 1,596,504 | $8.75M |
| Tang Capital Management LLC | 409,463 | $2.24M |
| Group One Trading, L.P. | 104,067 | $570.3K |
| Denali Advisors LLC | 87,500 | $479.5K |
| Cubist Systematic Strategies, LLC | 77,162 | $422.8K |
| Tejara Capital Ltd | 73,739 | $404.1K |
| Simplex Trading, LLC | 68,157 | $373.0K |
| ExodusPoint Capital Management, LP | 38,022 | $208.0K |
| Brendel Financial Advisors LLC | 18,281 | $100.0K |
| Mirae Asset Global Investments Co., Ltd. | 16,534 | $90.6K |
| Schonfeld Strategic Advisors LLC | 16,500 | $90.4K |
| AJOVista, LLC | 7,822 | $42.9K |